摘要
背景:结直肠癌(CRC)是一种高发肿瘤,尽管治疗方法不断更新和发展,但其治疗形势仍然十分困难。 目的:为结直肠癌患者的预后、监测和生存提供一个模型。 方法:在本研究中,我们建立了一个新的 CRC 预后模型。从GEO数据库中访问四组CRC数据,然后使用limma包和RobustRankAggreg包进行差异分析(logFoldChange>1,adjust-P<0.05),用于识别重叠差异表达基因(DEGs) )。对DEGs进行单变量和多变量Cox回归分析,筛选与患者预后相关的基因,构建五基因预后预测模型(包括RPX、CXCL13、MMP10、FABP4和CLDN23)。然后,我们进一步绘制了 ROC 曲线以评估 TCGA 数据集中五基因预后特征的预测性能(1、3、5 年生存期的 AUC 值分别为 0.68、0.632、0.675)和外部独立的数据集 GSE2962(1、3、5 年生存期的 AUC 值分别为 0.689、0.702、0.631)。 结果:结果表明,该模型能够有效预测CRC患者的预后,为CRC患者的预后提供了稳健的预测模型。 结论:该模型能够有效预测CRC患者的预后,为CRC患者的预后提供了稳健的预测模型。
关键词: 预后、特征、CRC、预测性、CLDN23、FABP4、MMP10、CXCL13。
Current Gene Therapy
Title:A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer
Volume: 21 Issue: 4
关键词: 预后、特征、CRC、预测性、CLDN23、FABP4、MMP10、CXCL13。
摘要:
Background: Colorectal cancer (CRC) is a kind of tumor with high incidence and its treatment situation is still very difficult despite the constant renewal and development of treatment methods.
Objective: To assist the prognosis, monitoring and survival of CRC patients with a model.
Methods: In this study, we established a new prognostic model for CRC. Four groups of CRC data were accessed from the GEO database, and then differential analysis (logFoldChange>1, adjust- P<0.05) was carried out by using the limma package along with the RobustRankAggreg package used to identify the overlapping differentially expressed genes (DEGs). Univariate and multivariate Cox regression analyses were performed on the DEGs to screen the genes related to the patient’s prognosis, and a five-gene prognostic prediction model (including RPX, CXCL13, MMP10, FABP4 and CLDN23) was constructed. Then, we further plotted ROC curves to evaluate the predictive performance of the five-gene prognostic signature in the TCGA data sets (the AUC values of 1, 3, 5-year survival were 0.68, 0.632, 0.675, respectively) and an external independent data set GSE2962 (the AUC values of 1, 3, 5-year survival were 0.689, 0.702, 0.631, respectively).
Results: The results showed that the model could effectively predict the prognosis of CRC patients, which provides a robust predictive model for the prognosis of CRC patients.
Conclusion: The model could effectively predict the prognosis of CRC patients, which provides a robust predictive model for the prognosis of CRC patients.
Export Options
About this article
Cite this article as:
A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer, Current Gene Therapy 2021; 21 (4) . https://dx.doi.org/10.2174/1566523220666201012151803
DOI https://dx.doi.org/10.2174/1566523220666201012151803 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Melatonin Signaling in Health and Disease
Melatonin regulates a multitude of physiological functions, including circadian rhythms, acting as a scavenger of free radicals, an anti-inflammatory agent, a modulator of mitochondrial homeostasis, an antioxidant, and an enhancer of nitric oxide bioavailability. AANAT is the rate-limiting enzyme responsible for converting serotonin to NAS, which is further converted to ...read more
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers.
Programmed cell death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
The now and future of gene transfer technologies
Gene and cell therapies rely on a gene delivery system which is safe and effective. Both viral and non-viral vector systems are available with specific pros and cons. The choice of a vector system is largely dependent on the application which is a balance between target tissue/disease and safety, efficacy ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Membrane-targeted Alkylphosphocholine Erufosine Interferes with Survival Signals from the Extracellular Matrix
Anti-Cancer Agents in Medicinal Chemistry Oxytocin - A Multifunctional Analgesic for Chronic Deep Tissue Pain
Current Pharmaceutical Design Inhibitors of the Hedgehog Signal Transduction Pathway
Current Cancer Therapy Reviews Inherited Copper Transport Disorders: Biochemical Mechanisms, Diagnosis, and Treatment
Current Drug Metabolism In vivo Fluorescence Detection in Surgery: A Review of Principles, Methods, and Clinical Applications
Current Medical Imaging State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
Recent Patents on Anti-Cancer Drug Discovery Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
Current Cancer Drug Targets Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds
Current Medicinal Chemistry Recent Advances in Flavivirus Antiviral Drug Discovery and Vaccine Development
Recent Patents on Anti-Infective Drug Discovery Kinase Inhibitors Involved in the Regulation of Autophagy: Molecular Concepts and Clinical Implications
Current Medicinal Chemistry Can PET Imaging Facilitate Optimization of Cancer Therapies?
Current Pharmaceutical Design Research Progress in Tumor Diagnosis Based on Raman Spectroscopy
Current Medical Imaging Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Advanced Ovarian Cancer: A 2-year Survival Analysis Study
Current Women`s Health Reviews Novel Hybrid Molecules of Quinazoline Chalcone Derivatives: Synthesis and Study of in vitro Cytotoxic Activities
Letters in Drug Design & Discovery The Use of Nimesulide and Its Analogues in Cancer Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry Cytochrome P450 2C8 and Drug Metabolism
Current Topics in Medicinal Chemistry Status of α-emitter Radioimmunoconjugates for Targeted Therapy
Current Radiopharmaceuticals Puerarin: A Review on the Pharmacological Activity, Chemical Properties and Pharmacokinetics of Main Isoflavonoid
The Natural Products Journal Herbal Drugs to Targets in the Treatment of Cancer - A Futuristic Approach
Current Cancer Therapy Reviews Ginger’s Antiapoptotic and Antioxidant Effects on Ovaries of Cyclophosphamide-therapied Rats
Current Pharmaceutical Design